drugset / Trial / NCT04358367

Intravenous Dexmedetomidine in Cesarean Section Under Spinal Anesthesia

NCT04358367

Phase 3 Completed 70 enrolled Egyptian Biomedical Research Network
RandomizedParallel-groupTriple-blindSupportive care

Summary

The present study hypothesized that intravenous dexmedetomidine use during spinal anesthesia for cesarean section has a beneficial influence on hemodynamic stability and epigastric pain together with satisfactory analgesic effects and excellent safety profile for the mother and the newborn.

Timeline

Start
2019-05-19
Primary completion
2019-10-19
Completion
2019-11-19

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg

Indications

No indication recorded.